Trump's 100% Drug Tariffs: What You Need to Know
Trump's 100% tariffs on imported brand-name drugs include tiered exemptions for companies committing to U.S. manufacturing and price reductions.
Public Health
The latest public health coverage from Hawaii Medical Journal.
Pharma Delays European Drug Launches Over US Pricing Policy
Drug manufacturers are delaying European launches as most-favored-nation pricing threatens to compress US revenues, reshaping global launch strategies in 2026.
Trump Pushes Drug Pricing Legislation in 2026
The White House is circulating draft drug pricing legislation to major pharma companies, escalating Trump's push to reshape U.S. medication pricing policy.
Parenting Challenges in Primary Care: The GP Workforce Gap
The suspension of GP Helen Eisenhauser highlights how primary care systems fail to support physician-parents, especially women managing childcare demands.
FTC Settles With CVS Over Insulin Price Manipulation
The FTC reached a proposed settlement with CVS Caremark over allegations its PBM artificially inflated insulin prices and blocked patient access.
By Robert Kim
24 States Sue EPA Over Greenhouse Gas Endangerment Rollback
A 24-state coalition sues the EPA over its rescission of the 2009 endangerment finding, with major public health and climate regulation implications.
Court Ruling Reverses RFK Jr.'s Vaccine Policy Changes
A federal judge reversed HHS vaccine policy changes by RFK Jr., restoring the childhood vaccine schedule and creating a crossroads for the Trump administration.
Auto-Enrollment in Medicare Advantage Plans Under Review 2026
CMS is evaluating automatic enrollment of Medicare beneficiaries into Medicare Advantage plans or ACOs, a major policy shift under the Trump administration.